Irritable Bowel Syndrome and Food Sensitivity
| Status: | Completed |
|---|---|
| Conditions: | Irritable Bowel Syndrome (IBS), Neurology |
| Therapuetic Areas: | Gastroenterology, Neurology |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 10/20/2017 |
| Start Date: | July 2014 |
| End Date: | January 2016 |
Irritable Bowel Syndrome and Food Sensitivity: Assessing Clinical Outcomes and Inflammatory Cellular Pathways
The primary objective of the clinical trial portion of this study is to assess whether an
individualized dietary plan based on a commercial food sensitivity assay provides specific
benefit in a randomized controlled trial in adults with irritable bowel syndrome (IBS).
individualized dietary plan based on a commercial food sensitivity assay provides specific
benefit in a randomized controlled trial in adults with irritable bowel syndrome (IBS).
This is a parallel group, randomized control trial, powered to assess changes in validated
outcomes in adult patients with symptomatic irritable bowel syndrome. Subjects will receive
dietary counseling and be asked to adhere to dietary instructions for 4 weeks. Assessments
will occur at baseline, 4-weeks, and 8-weeks post-baseline.
outcomes in adult patients with symptomatic irritable bowel syndrome. Subjects will receive
dietary counseling and be asked to adhere to dietary instructions for 4 weeks. Assessments
will occur at baseline, 4-weeks, and 8-weeks post-baseline.
Inclusion Criteria:
- Between 18-70 years of age.
- Irritable Bowel Syndrome by Rome III criteria.
- Stable dose (30 days) of concurrent IBS medications
- Agree not to make significant changes to their diet during the study
- IBS-SSS score of >150
Exclusion Criteria:
- History of major abdominal surgeries
- History of inflammatory bowel disease
- Antibiotic use within 1 month of enrollment
- Radiation proctitis or other known poorly controlled medical conditions that could
interfere with bowel function
- Current use of opioid pain medications (except for NSAIDs)
- Previous experience participating in dietary studies for IBS
- Current use of medications which are known to be affected by modest dietary changes
- Vitamin C use of >2000 mg/day
- Quercetin use of >500 mg/day
We found this trial at
1
site
Yale University Yale's roots can be traced back to the 1640s, when colonial clergymen led...
Click here to add this to my saved trials
